Centogene Company

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients.
Technology: Genetic Test & Molecular Diagnostics
Industry: Mitochondrial Genetics
Headquarters: Germany
Founded Date: 2006
Investors Number: 1
Total Funding: $6.9M
Estimated Revenue: $50M to $100M
Last Funding Type: Grant

Visit Website
socialmedia@centogene.com
https://twitter.com/Centogene
Register and Claim Ownership